Synaptic biomarkers in the cerebrospinal fluid associate differentially with classical neuronal biomarkers in patients with Alzheimer’s disease and frontotemporal dementia

BACKGROUND: Loss of synaptic functionality has been recently identified as an early-stage indicator of neurological diseases. Consequently, monitoring changes in synaptic protein levels may be relevant for observing disease evolution or treatment responses in patients. Here, we have studied the rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Shreyasee, Goossens, Julie, Jacobs, Dirk, Dewit, Nele, Pijnenburg, Yolande A. L., In ‘t Veld, Sjors G. J. G., Teunissen, Charlotte E., Vanmechelen, Eugeen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037899/
https://www.ncbi.nlm.nih.gov/pubmed/36964594
http://dx.doi.org/10.1186/s13195-023-01212-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037899/
https://www.ncbi.nlm.nih.gov/pubmed/36964594
http://dx.doi.org/10.1186/s13195-023-01212-x

Ejemplares similares